Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Time-Restricted eating shows promise for psoriasis inflammation

NCT ID NCT04728165

First seen May 15, 2026 · Last updated Jun 23, 2026 · Updated 5 times

Summary

This pilot study tested whether time-restricted feeding (eating all daily calories between 8am and 2pm, then fasting for 18 hours) could reduce inflammation in men with mild to moderate psoriasis. 27 participants (including healthy volunteers) stayed at the clinic for 4.5 days, wore glucose monitors, and completed meal tests. The study measured changes in immune cell activity and other markers of inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

time-restricted feeding (eating only between 8am and 2pm each day)

What this could lead to

If it works, this could point toward a simple dietary approach to help manage inflammation in psoriasis.

What could go wrong

This is a very small pilot study (27 people) that only looks at blood markers, not actual skin improvement. It may not lead to any practical treatment.

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.